Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models
Seth E. Karol(St. Jude Children's Research Hospital), Mary V. Relling(St. Jude Children's Research Hospital), David Jenkins(Manchester Academic Health Science Centre), William E. Evans(St. Jude Children's Research Hospital), John C. Panetta(St. Jude Children's Research Hospital), Laura B. Ramsey(University of Cincinnati Medical Center), Monique A. Payton(St. Jude Children's Research Hospital), Laura J. Janke(St. Jude Children's Research Hospital), Xiangjun Cai(Shenyang 242 Hospital)
Cited by 12
Related Papers
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
|New England Journal of Medicine|2009|1.2k